Clinical Trial Update: Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on boosting strategies after vaccination with ALVAC-HIV and AIDSVAX B/E for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• AIDSVAX B/E
• ALVAC-HIV

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: HIV Infections | Phase 2 | Status: UNKNOWN